FDA Scraps Demands On Clinical Trial Falsity Reports
The U.S. Food and Drug Administration has abandoned a controversial proposal to force drug and device makers to disclose data manipulation in clinical trials, saying the move isn't needed to protect...To view the full article, register now.
Already a subscriber? Click here to view full article